Circulating levels of osteoprotegerin and sRANKL and the effect of methotrexate in patients with rheumatoid arthritis
Background: Receptor activator of nuclear factor κβ ligand (RANKL) and osteoprotegerin (OPG) are pivotal molecules involved in osteoclast activation and resorption. In RA, their alterations mediated through inflammatory cytokines are responsible for erosions and systemic bone loss. This study planne...
Saved in:
Main Authors: | Aadhaar Dhooria, Narendhiran Pandurangan, Karthik Vinay Mahesh, Suchet Sachdev, Aman Sharma, Shefali Sharma, Nidhi Gupta, Varun Dhir |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=2;spage=90;epage=94;aulast=Dhooria |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Osteoprotegerin as an Emerging Biomarker of Carotid Artery Stenosis? A Scoping Review with Meta-Analysis
by: Jerzy Chudek, et al.
Published: (2025-01-01) -
Mechanism of Bushen Huoxue Recipe on Improving Arterial Calcification in Rats with Osteoporosis Based on OPG/RANKL Signaling Pathway
by: LIN Xiaorong, et al.
Published: (2022-08-01) -
Management of Ectopic Pregnancy: Comparison of Systemic Methotrexate Administration and Surgical Treatment; A Retrospective Study
by: Ali Cenk Özay, et al.
Published: (2013-08-01) -
Frequency and Causes of Methotrexate Intolerance and Discontinuation in Rheumatoid Arthritis Patients in Qena Governorate
by: Sondos Mohammed Sayed, et al.
Published: (2024-07-01) -
Quantitating skin thickness in systemic sclerosis: The way ahead
by: Shefali Sharma, et al.
Published: (2017-01-01)